Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Harnessing Muscle-specific Atrophy Susceptibility to Disentangle the Mechanisms of Disuse Atrophy in Human Skeletal Muscle Atrophy (iMOB)

NCT04199923 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT04199923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04199923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Harnessing Muscle-specific Atrophy Susceptibility to Disentangle the Mechanisms of Disuse Atrophy in Human Skeletal Muscle Atrophy (iMOB)
Lead sponsor
University of Nottingham
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 1, 2019
Completion date
October 1, 2026
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immobility syndrome, muscular atrophy